Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.

Calprotectin: a novel noninvasive marker for intestinal allograft monitoring.

Sudan D, Vargas L, Sun Y, Bok L, Dijkstra G, Langnas A.

Ann Surg. 2007 Aug;246(2):311-5.

2.

Evaluation of calprotectin level in intestinal content as an early marker for graft rejection.

Cagnola H, Scaravonati R, Cabanne A, Bianchi C, Gruz F, Errea A, Zambernardi A, Meier D, Chirdo F, Docena G, Gondolesi G, Rumbo M.

Transplant Proc. 2010 Jan-Feb;42(1):57-61. doi: 10.1016/j.transproceed.2009.12.013.

PMID:
20172281
3.

Fecal calprotectin level measurements in small bowel allograft monitoring: a pilot study.

Akpinar E, Vargas J, Kato T, Smith L, Hernandez E, Selvaggi G, Nishida S, Moon J, Island E, Levi D, Ruiz P, Tzakis AG.

Transplantation. 2008 May 15;85(9):1281-6. doi: 10.1097/TP.0b013e31816dcea2.

PMID:
18475184
4.

Stool calprotectin monitoring after small intestine transplantation.

Mercer DF, Vargas L, Sun Y, Moreno AM, Grant WJ, Botha JF, Langnas AN, Sudan DL.

Transplantation. 2011 May 27;91(10):1166-71. doi: 10.1097/TP.0b013e318215e709.

PMID:
21460762
5.

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.

Sidler MA, Leach ST, Day AS.

Inflamm Bowel Dis. 2008 Mar;14(3):359-66.

PMID:
18050298
6.

Hot topics in postsmall bowel transplantation: noninvasive graft monitoring including stool calprotectin and plasma citrulline.

Mercer DF.

Curr Opin Organ Transplant. 2011 Jun;16(3):316-22. doi: 10.1097/MOT.0b013e3283467115. Review.

PMID:
21505339
7.

Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.

Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.

Dig Liver Dis. 2008 Jul;40(7):547-53. doi: 10.1016/j.dld.2008.01.017. Epub 2008 Mar 20.

PMID:
18358796
8.

Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.

Kallel L, Ayadi I, Matri S, Fekih M, Mahmoud NB, Feki M, Karoui S, Zouari B, Boubaker J, Kaabachi N, Filali A.

Eur J Gastroenterol Hepatol. 2010 Mar;22(3):340-5. doi: 10.1097/MEG.0b013e32832bab49.

PMID:
19581809
9.

Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.

Diamanti A, Colistro F, Basso MS, Papadatou B, Francalanci P, Bracci F, Muraca M, Knafelz D, De Angelis P, Castro M.

Inflamm Bowel Dis. 2008 Sep;14(9):1229-35. doi: 10.1002/ibd.20472.

PMID:
18398894
10.

Sustained elevated concentrations of cardiac troponin T during acute allograft rejection after heart transplantation in children.

Wåhlander H, Kjellström C, Holmgren D.

Transplantation. 2002 Oct 27;74(8):1130-5.

PMID:
12438959
11.

Faecal calprotectin: a marker of inflammation throughout the intestinal tract.

Summerton CB, Longlands MG, Wiener K, Shreeve DR.

Eur J Gastroenterol Hepatol. 2002 Aug;14(8):841-5.

PMID:
12172403
12.

A schema for histologic grading of small intestine allograft acute rejection.

Wu T, Abu-Elmagd K, Bond G, Nalesnik MA, Randhawa P, Demetris AJ.

Transplantation. 2003 Apr 27;75(8):1241-8.

PMID:
12717210
13.

Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.

Walkiewicz D, Werlin SL, Fish D, Scanlon M, Hanaway P, Kugathasan S.

Inflamm Bowel Dis. 2008 May;14(5):669-73. doi: 10.1002/ibd.20376.

PMID:
18240279
14.

Fecal calprotectin as a predictor of abnormal colonic histology.

Shitrit AB, Braverman D, Stankiewics H, Shitrit D, Peled N, Paz K.

Dis Colon Rectum. 2007 Dec;50(12):2188-93.

PMID:
17963005
15.

Assessment of ileal pouch inflammation by single-stool calprotectin assay.

Thomas P, Rihani H, Røseth A, Sigthorsson G, Price A, Nicholls RJ, Bjarnason I.

Dis Colon Rectum. 2000 Feb;43(2):214-20.

PMID:
10696896
16.

Can calprotectin predict relapse risk in inflammatory bowel disease?

D'Incà R, Dal Pont E, Di Leo V, Benazzato L, Martinato M, Lamboglia F, Oliva L, Sturniolo GC.

Am J Gastroenterol. 2008 Aug;103(8):2007-14.

PMID:
18802997
17.

Zoom endoscopic monitoring of small bowel allograft rejection.

Kato T, Gaynor JJ, Nishida S, Mittal N, Selvaggi G, Levi D, Moon J, Thompson J, Ruiz P, Madariaga J, Tzakis AG.

Surg Endosc. 2006 May;20(5):773-82. Epub 2006 Mar 16.

PMID:
16544078
18.

Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.

Fagerberg UL, Lööf L, Myrdal U, Hansson LO, Finkel Y.

J Pediatr Gastroenterol Nutr. 2005 Apr;40(4):450-5.

PMID:
15795593
19.

A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.

Johne B, Kronborg O, Tøn HI, Kristinsson J, Fuglerud P.

Scand J Gastroenterol. 2001 Mar;36(3):291-6.

PMID:
11305517
20.

Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.

Abraham SC, Poterucha JJ, Rosen CB, Demetris AJ, Krasinskas AM.

Am J Surg Pathol. 2008 Jul;32(7):965-73. doi: 10.1097/PAS.0b013e3181622490.

PMID:
18460980

Supplemental Content

Support Center